Mammatech Launches New Breast Cancer Screening Program with OHSU Cancer Institute
GAINESVILLE, Fla., Oct 7, 2003 (BUSINESS WIRE) -- MammaCare and The OHSU Cancer Institute will launch a new program for breast cancer screening, the Mammatech Corporation (OTCBB:MAMH) announced today. The Oregon Health & Sciences University Cancer Institute will host a MammaCare(R) Training Center at OHSU's Cancer Institute to train and certify health professionals to conduct highly effective clinical breast examinations (CBE) and will work closely with Mammatech on advances in training technology. MammaCare, whose development was supported by the National Cancer Institute, is the skill-based program for teaching and performing CBE and for teaching women to perform proficient breast self-examination.
Dr. Henry Pennypacker, President of The Mammatech Corporation, said "Partnership with the OHSU Cancer Center will measurably increase the availability and quality of breast cancer screening for many thousands of women." Dr. Mark Goldstein, Mammatech's Chairman, reported that "fingers still discover the majority of breast cancers and skill-based training is an essential requirement for effective breast exams."
The Grand opening of the MammaCare Training Center at the OHSU Cancer Center will take place on the campus of OHSU at the Hartfield Research Center in Portland Oregon on Thursday October 9th 2003. Attending will be scientists and physicians from OHSU, Harvard University, the University of Washington, the Centers for Disease Control and Prevention and Mammatech.
MammaCare(R) is the registered trademark of the Mammatech Corporation, a publicly held company: symbol mamh.ob
The Mammatech Corporation believes that this release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's beliefs and are subject to performance and outcomes that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to review Mammatech's filings with the Securities and Exchange Commission.
SOURCE: Mammatech Corporation
This is not a reco to buy! Please do your DD!
